Search research articles
Contact Us
Filters
Showing results (81-90 of 269) with videos related to
Page
of 27
Sort By:
The Lancet. Gastroenterology & Hepatology
|
June 20, 2020
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
Brian G Feagan, William J Sandborn, Silvio Danese, et al.
United European Gastroenterology Journal
|
November 9, 2019
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®<sup>MMX®</sup>) for active, mild-to-moderate ulcerative colitis
Silvio Danese, Ailsa Hart, Axel Dignass, et al.
Expert Review of Clinical Pharmacology
|
March 5, 2024
Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis
Geert D'Haens, Maria Rosario, Daniel Polhamus, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Transperineal ultrasonography in detecting penetrating perianal disease: a systematic review and meta-analysis
Chong-Teik Lim, Maarten Pruijt, Gek-Hsiang Lim, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry
Edward V Loftus, Walter Reinisch, Remo Panaccione, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 19, 2021
Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Steven J Bots, Claire E Parker, Johannan F Brandse, et al.
Gut
|
September 28, 2011
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
Gert Van Assche, Séverine Vermeire, Vera Ballet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 5, 2013
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease
Jean-Frédéric Colombel, William J Sandborn, Matthieu Allez, et al.
Advances in Therapy
|
November 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants
Yuki Otani, Christopher D Payne, Edward V Loftus, et al.
Crohn'S & Colitis 360
|
August 28, 2023
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies
William J Sandborn, Jingjing Chen, Krisztina Kisfalvi, et al.
Page
of 27
Search research articles
Search
Showing results (81-90 of 269) with videos related to
Sort By:
Page
of 27
The Lancet. Gastroenterology & Hepatology
|
June 20, 2020
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
Brian G Feagan, William J Sandborn, Silvio Danese, et al.
United European Gastroenterology Journal
|
November 9, 2019
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®<sup>MMX®</sup>) for active, mild-to-moderate ulcerative colitis
Silvio Danese, Ailsa Hart, Axel Dignass, et al.
Expert Review of Clinical Pharmacology
|
March 5, 2024
Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis
Geert D'Haens, Maria Rosario, Daniel Polhamus, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Transperineal ultrasonography in detecting penetrating perianal disease: a systematic review and meta-analysis
Chong-Teik Lim, Maarten Pruijt, Gek-Hsiang Lim, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry
Edward V Loftus, Walter Reinisch, Remo Panaccione, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 19, 2021
Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Steven J Bots, Claire E Parker, Johannan F Brandse, et al.
Gut
|
September 28, 2011
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
Gert Van Assche, Séverine Vermeire, Vera Ballet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 5, 2013
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease
Jean-Frédéric Colombel, William J Sandborn, Matthieu Allez, et al.
Advances in Therapy
|
November 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants
Yuki Otani, Christopher D Payne, Edward V Loftus, et al.
Crohn'S & Colitis 360
|
August 28, 2023
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies
William J Sandborn, Jingjing Chen, Krisztina Kisfalvi, et al.
Page
of 27